Navigation Links
WuXi PharmaTech Announces First-Quarter 2010 Results
Date:5/11/2010

y be subject to future regulatory or legislative actions and other risk factors. These other risk factors include: continued uncertainty in the global economy, the pressures being felt by our customers, and pharmaceutical industry consolidation may adversely impact our business and the trends for outsourced R&D and manufacturing for longer than expected or more severely than expected; we may be unable to successfully make our planned investments and capital expenditures on a timely basis, these investments may not yield the desired results, and we may need to modify the nature and level of our investments and capital expenditures; pharmaceutical companies may not change their business models as expected or in a manner favorable to us; we may fail to capitalize on the opportunities presented; we may not maintain our preferred provider status with our clients and may be unable to successfully expand our capabilities to meet client needs. In addition, other factors that could cause our actual results to differ from what we currently anticipate include failure to generate sufficient future cash flows or to secure any required future financing on acceptable terms or at all; failure to retain key personnel; effective integration of continuing products and services from AppTec; our reliance on a limited number of customers to continue to account for a high percentage of our revenues; risk of payment failure by any of our large customers, which could significantly harm our cash flows and profitability; dependence upon the continued service of our senior management and key scientific personnel; and our ability to retain our existing customers or expand our customer base. You should read the financial information contained in this release in conjunction with the consolidated financial statements and related notes thereto included in our 2009 Annual Report on Form 20-F filed with and available on the Securities and Exchange Commission's ("SEC's") website at
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
2. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
3. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
6. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
7. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
8. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
9. Jazz Pharmaceuticals Announces Public Offering of Common Stock
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
11. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... expects revenues for the fourth quarter of 2013 will ... to approximately $208 million. "Our full-year revenue ...
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new ... targeting guide with accompanying instrumentation to place and insert ... to the soft tissue (e.g. ligament) repair or reconstruction ... repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... Pfizer Inc. (NYSE: PFE ) today announced ... Read, 57, currently head of the Company,s global biopharmaceutical ... Read succeeds Jeffrey B. Kindler, who has retired from ... The Board,s Lead Independent Director, Constance J. Horner, said, ...
... Dec. 3, 2010 Opto Circuits (India) Ltd. [BSE ... completed the merger of its wholly-owned subsidiary, Jolt Acquisition ... result of the transaction, Cardiac Science has become a ... follows (i) Opto Circuits, acquisition, through a tender offer ...
Cached Medicine Technology:Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 2Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 3Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer 4Opto Circuits Successfully Completes Acquisition of Cardiac Science 2Opto Circuits Successfully Completes Acquisition of Cardiac Science 3
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
(Date:4/17/2014)... NEW YORK (17 April 2014) Population Council scientists and ... is safe, stable, and can prevent the transmission of ... and rectum in animals: HIV, herpes simplex virus 2 ... provides the first data that the gel is effective ... of efficacy in the vagina against all three viruses ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... published in volume 14 issue 6 of World ... presented to Dr Cosimo Sperti of University of ... laparotomy performed in another hospital for an unresectable ... vein. Total pancreatectomy together with resection and reconstruction ...
... Ph.D., MBA, RN is vice president of research,and ... announced it,has appointed Joann Genovich-Richards, Ph.D., MBA, RN, ... research and measurement. The,position will support the development ... analyze existing data from accredited companies and,other sources ...
... March 13 inVentiv Clinical,Solutions, LLC (inVentiv Clinical), ... that they will establish operations in Latin,America, a ... will be,based in Sao Paulo, Brazil, with the ... inVentiv Clinical,s Latin American operations,will be led by ...
... TOC ; TSX: TOC) has been selected by ... care hospitals in high-growth urban and,suburban markets, to complete ... care hospitals., Like other health systems in the ... a limited field of candidates.,Thomson Healthcare, using its Market ...
... Ohio, March 13 Cardinal Health, a,global ... the safety and,productivity of health care, today ... Kaufmann as group president of its Healthcare ... role, Kaufmann, 45, will be responsible for ...
... the Future, JACKSON, Miss., March 13 ... technology partner, announces Christwood Retirement,Community in Covington, ... Study,(OBS) partner site for SamarionSolution(SM), the nursing ... Christwood, which recently celebrated a decade as ...
Cached Medicine News:Health News:URAC Announces New Leadership to Mine Health Care Management Data and Develop Measurement Programs 2Health News:URAC Announces New Leadership to Mine Health Care Management Data and Develop Measurement Programs 3Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 2Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 3Health News:Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare 2Health News:Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare 3Health News:Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment 2Health News:Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industry's Only Enterprise Quality Improvement System 2Health News:Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industry's Only Enterprise Quality Improvement System 3
Reagent Basin, 60mL, 5/Box...
Reservoir, 8 Well, 10/Box...
... manually adjustable dispensing head, and disposable, pre-sterilized ... cost-efficiency to microplate fluid dispensing. It is ... offer fast dispensing of fluids in a ... It also offers the added benefit of ...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat...
Medicine Products: